Asian Tech Press (Nov 20) -- Chinese pharmaceutical company Boji Medical Technology Co., Ltd (300404.SZ, Boji) disclosed on Sunday that it has set up an overseas subsidiary for clinical services.

Several investment institutions, including Zhongtai Securities, Ruixin Investment and Guangzhou Googolpark, conducted research on the company on Nov. 17, 2023, Boji said in a release.

During the period, the contract research organization (CRO) disclosed that its business is currently dominated by domestic clients, with its main revenues coming from within the country.

And the company said that this year, it also set up a subsidiary for clinical services overseas, in an effort to gradually explore foreign markets.